Yttrium-90 radioembolization for unresectable, chemoresistant breast cancer liver metastases: a large single-center experience of 40 patients

Annals of Surgical Oncology
Akshat SaxenaLourens Bester

Abstract

There are a paucity of data on the treatment of unresectable, chemoresistant breast cancer liver metastases (BRCLM) with yttrium-90 (Y90) radioembolization. Forty patients underwent resin-based Y90 radioembolization for unresectable, chemoresistant BRCLM between 2006 and 2012 in a single institution. All patients were followed up with imaging studies at regular intervals as clinically indicated until death. Radiologic response was evaluated with the Response Criteria in Solid Tumors criteria. Clinical toxicities were prospectively recorded as per the National Cancer Institute Common Toxicity Criteria. Survival was calculated by the Kaplan-Meier method and potential prognostic variables were identified on univariate and multivariate analysis. Follow-up was complete in all patients. The median follow-up was 11.2 (range 0.6-30.5) months and the median survival after Y90 radioembolization was 13.6 months, with a 24-month survival of 39 %. On imaging follow-up of 38 patients who survived beyond 1 month of treatment, a complete response (CR) to treatment was observed in two patients (5 %), partial response (PR) in 10 patients (26 %), stable disease (SD) in 15 patients (39 %), and progressive disease (PD) in 11 patients (29 %). Two fa...Continue Reading

References

Aug 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·K PorkkaS Pyrhönen
Jan 1, 1994·Journal of Surgical Oncology·S SchneebaumJ P Minton
Sep 21, 2006·Journal of the National Cancer Institute·Davide MauriJohn P A Ioannidis
Nov 24, 2006·Annals of Surgery·René AdamDenis Castaing
May 15, 2007·Journal of Vascular and Interventional Radiology : JVIR·Affaan K BangashRiad Salem
May 26, 2007·International Journal of Radiation Oncology, Biology, Physics·Douglas M ColdwellCharles W Nutting
Apr 29, 2008·Journal of Vascular and Interventional Radiology : JVIR·Tobias F JakobsThomas K Helmberger
Aug 13, 2008·Journal of the National Cancer Institute·Abenaa M BrewsterFrancisco J Esteva
Aug 30, 2008·Journal of Vascular and Interventional Radiology : JVIR·Jourdan E StuartDaniel B Brown
Jul 18, 2009·Annals of Oncology : Official Journal of the European Society for Medical Oncology·S BeslijaUNKNOWN Central European Cooperative Oncology Group (CECOG)
Feb 10, 2010·Annals of Surgical Oncology·Katrin HoffmannPeter Schemmer
Sep 23, 2010·Journal of Cancer Research and Clinical Oncology·Terence C ChuaDavid L Morris
Jul 12, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Terence C ChuaDavid L Morris
Feb 15, 2012·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Alexander R HaugMarcus Hacker
Jan 22, 2013·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Apr 3, 2013·European Journal of Pharmacology·Maarten L J SmitsMaurice A A J van den Bosch
Apr 23, 2013·Journal of Vascular and Interventional Radiology : JVIR·Samdeep MouliRobert J Lewandowski

❮ Previous
Next ❯

Citations

Aug 27, 2014·Journal of Vascular and Interventional Radiology : JVIR·Andrew C GordonRobert J Lewandowski
May 18, 2016·Indian Journal of Gastroenterology : Official Journal of the Indian Society of Gastroenterology·Vankadari KousikArun Gupta
May 31, 2016·Seminars in Nuclear Medicine·Murat Fani BozkurtÖmer Uğur
Jul 28, 2016·Journal of Vascular and Interventional Radiology : JVIR·Claus Christian PieperHans Heinz Schild
Aug 28, 2016·Journal of Vascular and Interventional Radiology : JVIR·Andrew C GordonRobert J Lewandowski
Nov 12, 2016·Journal of Vascular and Interventional Radiology : JVIR·Siddharth A PadiaUNKNOWN Society of Interventional Radiology Standards of Practice Committee
Nov 22, 2016·The Cancer Journal·Erica S Alexander, Michael C Soulen
Jun 2, 2016·World Journal of Radiology·Andreas H Mahnken
Nov 17, 2019·Cardiovascular and Interventional Radiology·Amy R DeipolyiConstantinos T Sofocleous
Jul 29, 2015·World Journal of Gastroenterology : WJG·Andrew KueiEdward Wolfgang Lee
Jun 1, 2014·Hepatic Oncology·Ryan M HickeyRiad Salem
Sep 14, 2019·Cancers·Reto BalePeter Schullian
Feb 28, 2020·World Journal of Gastrointestinal Oncology·Michael Feretis, Andriy Solodkyy
Dec 18, 2020·Seminars in Interventional Radiology·Ariel N Liberchuk, Amy R Deipolyi
Jan 22, 2021·European Journal of Radiology·Fourat RidouaniAmy R Deipolyi
Jan 9, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Wolfgang P FendlerAlexander R Haug
Jul 30, 2021·Cardiovascular and Interventional Radiology·B M AartsE G Klompenhouwer

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.